Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Emergency/Compassionate Use - AMPLATZER Duct Occluder

Expanded access is no longer available for this treatment.
Sponsor:
Information provided by:
AGA Medical Corporation
ClinicalTrials.gov Identifier:
NCT00583583
First received: December 20, 2007
Last updated: December 28, 2007
Last verified: December 2007

December 20, 2007
December 28, 2007
Not Provided
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00583583 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Emergency/Compassionate Use - AMPLATZER Duct Occluder
Not Provided

Emergency/compassionate use for the AMPLATZER Duct Occluder

Not Provided
Expanded Access
Not Provided
Not Provided
  • Patent
  • Ductus
  • Arteriosus
Device: Device closure with the AMPLATZER Duct Occluder
Device closure with the AMPLATZER Duct Occluder
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
No longer available
Not Provided
Not Provided
Not Provided

Inclusion Criteria:

  • Emergency/compassionate use for patients not meeting the inclusion crtieria for the AMPLATZER Duct Occluder clinical trial
Both
Not Provided
Not Provided
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
NCT00583583
AGA-004 E/C, G980103
Not Provided
Ken Lock, AGA Medical Corporation
AGA Medical Corporation
Not Provided
Not Provided
AGA Medical Corporation
December 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP